Browsing: BeOne

China’s ascendant drug industry is no monolith, despite how it’s often described by Western competitors, pundits, and policymakers. The country is home to scores of companies with diverging ambitions, founded last year or last century, each vying for attention and capital amid a domestic scientific renaissance and a geopolitical standoff.